RxDoctor Payments Data

Alexandra Riguero, PA

Physician Assistant · Miami, FLNPI 1336510742

Payments from drug & device makers

$7,654in general payments, 2019–2025

Across 345 payments — averaging $22.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$2K
  • AbbVie$1K
  • UCB, Inc.$594
  • Lilly USA, LLC$433
  • Galderma Laboratories, L.p.$405
  • E.r. Squibb & Sons, L.L.C.$387
  • plus $3K from 25 others

What the payments were for

  • Food & beverage$7,16894%
  • Education$4866%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,654 in reported general payments places this provider in the 95th percentile of 8,062 physician assistant providers in Florida.

See all physician assistant providers in Florida

Medicare billing

Part B allowed, 2024
$11,459
Medicare patients
47
Services billed
147

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa32$662,341
Cosentyx Sensoready (2 Pens)Secukinumab32$232,311
Cosentyx Unoready PenSecukinumab18$158,306
Taltz AutoinjectorIxekizumab13$88,314
Ketoconazole384$5,754
Clobetasol Propionate103$4,024
Metronidazole48$3,705
Betamethasone Dipropionate85$3,331
Ciclopirox67$3,084
Clindamycin Phosphate85$2,663
Fluorouracil24$2,259
Azelaic Acid14$1,043
Triamcinolone Acetonide131$1,002
CiclopiroxCiclopirox Olamine37$637
Imiquimod16$618

Paid to pharmacies, not to this prescriber.

Other physician assistant in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →